Dear Colleague,
Please find attached a revised – HSS(MD)59/2020 – Seasonal Influenza Vaccination Programme 20/21.
Yours sincerely
Vanessa
Sent on behalf of Dr Vanessa Chambers | Head of Policy & Development
Archives: Contractor Email
As at 25th August 2020 – Sent to Contractors who have not Responded
*** URGENT REMINDER ***
Sent: 20 August 2020 16:33
Subject: HSCNI Secure Email
Importance: High
Dear Colleague,
We are following up with pharmacies who have not, as yet, responded to the test email sent by your local HSCB office on 19th March 2020. We have attached the relevant correspondence relating to this and a copy of the test email is provided below.
Subject: HSCB Test Email & Communication Policy – Please Respond
Dear Colleague,
This is a test email issued via the HSCB to both provide you with a copy of the Primary Care Email Communication Policy and test access to your HSC Secure Email for the first time.
Please read the attached Primary Care Email Communications Policy and respond to this email confirming receipt and agreement with the policy. Once your response to this
email confirming agreement with the communications policy has been received, the HSCB will be in a position to commence email communications with your pharmacy
(all communications issued via email will also be issued via hard copy post for a period of time).
If there is anything you would like to discuss in relation to the HSC secure email for community pharmacies or the attached communications policy, please contact your local Practice
Support Manager in the first instance. If you can access this email and are content with the attached communications policy, simply reply to this email address confirming receipt
and acceptance of the communications policy. The HSCB will then commence email communications with your pharmacy using your HSC secure email address (with information
additionally being issued via hard copy post for a limited period of time).
We appreciate this came at an extremely busy time for community pharmacy and are also aware that some technical difficulties have been experienced, we hope these issues have now been resolved.
The use of secure email will be particularly important to support services from September onwards, including the new HSC commissioned flu vaccination service, it will also form a critically important means of communication within a potential COVID-19 second wave.
We would strongly encourage you to take steps to get connected by responding to the test email sent by HSCB on 19th March 2020 as soon as possible.
If you are having any difficulties please contact your local HSCB office to get these addressed.
Yours sincerely
SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive
Download
Dear Colleague
LITHIUM CARBONATE (PRIADEL®) 200MG AND 400MG MODIFIED RELEASE TABLETS – SUPPLY DISRUPTION ALERT
Please see attached letter from Dr. Michael McBride, Chief Medical Officer and Cathy Harrison, Chief Pharmaceutical Officer.
Yours sincerely
SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive
Download
*** FINAL REMINDER – RETURN DUE BY CLOSE OF BUSINESS MONDAY 24TH AUGUST 2020 ***
From: CPNIContractorUpdate
Sent: 19 August 2020 15:16
Subject: *** URGENT REMINDER *** CPNI COVID19 ContractorUpdate #121 RE: Expression of Interest to Provide Flu Vaccination Services 2020/21
Importance: High
*** URGENT REMINDER ***
From: CPNIContractorUpdate
Sent: 13 August 2020 17:32
Subject: *** URGENT *** CPNI COVID19 ContractorUpdate #121 RE: Expression of Interest to Provide Flu Vaccination Services 2020/21
Importance: High
***** IMPORTANT – FLU VACCINATION SERVICE 2020/21 OPPORTUNITY ****
Dear Contractor
Please find attached an Expressions of Interest letter and a Service Contract to be completed by all contractors wishing to provide a commissioned Flu Vaccination Service in 2020/21. Contractors offering to provide the service are required to do so in line with the National Minimum Standards and Core Curriculum for Immunisation Training, Flu Vaccination Service Specification and have an appropriate standard operating procedure in place.
Contractors should note the tight timescale for responses, with signed contracts required to be returned by email by close of play Monday 24th August 2020.
Yours sincerely
Vanessa
Sent on behalf of Dr Vanessa Chambers | Head of Policy & Development
Download
Dear Colleague,
Further concessionary prices have been granted for August 2020:
| Drug | Pack Size | Concessionary Price |
| Adrenaline (base) 150micrograms/0.15ml (1 in 1,000) solution for injection pre-filled disposable devices | 1 | £34.30 |
| Duloxetine 20mg gastro-resistant capsules | 28 | £7.74 |
| Duloxetine 40mg gastro-resistant capsules | 56 | £12.39 |
| Enalapril 20mg tablets | 28 | £7.20 |
| Exemestane 25mg tablets | 30 | £41.00 |
| Imipramine 25mg tablets | 28 | £6.40 |
| Irbesartan 150mg tablets | 28 | £6.80 |
| Moxonidine 200microgram tablets | 28 | £9.72 |
| Moxonidine 400microgram tablets | 28 | £12.13 |
| Naftidrofuryl 100mg capsules | 84 | £6.99 |
| Olanzapine 20mg tablets | 28 | £6.77 |
| Prednisolone 10mg tablets | 30 | £16.22 |
| Prednisolone 2.5mg tablets | 30 | £4.19 |
| Senna 7.5mg tablets | 60 | £2.76 |
| Sertraline 50mg tablets | 28 | £5.27 |
| Tolterodine 1mg tablets | 56 | £16.43 |
Kind regards,
Katherine
SENT FOR AND BEHALF OF KATHERINE KIDD | Head of Pharmacy Development
*** FAO Independent Contractors who have not Responded ***
Dear Colleague,
We are following up with pharmacies who have not, as yet, responded to the test email sent by your local HSCB office on 19th March 2020. We have attached the relevant correspondence relating to this and a copy of the test email is provided below.
Subject: HSCB Test Email & Communication Policy – Please Respond
Dear Colleague,
This is a test email issued via the HSCB to both provide you with a copy of the Primary Care Email Communication Policy and test access to your HSC Secure Email for the first time.
Please read the attached Primary Care Email Communications Policy and respond to this email confirming receipt and agreement with the policy. Once your response to this
email confirming agreement with the communications policy has been received, the HSCB will be in a position to commence email communications with your pharmacy
(all communications issued via email will also be issued via hard copy post for a period of time).
If there is anything you would like to discuss in relation to the HSC secure email for community pharmacies or the attached communications policy, please contact your local Practice
Support Manager in the first instance. If you can access this email and are content with the attached communications policy, simply reply to this email address confirming receipt
and acceptance of the communications policy. The HSCB will then commence email communications with your pharmacy using your HSC secure email address (with information
additionally being issued via hard copy post for a limited period of time).
We appreciate this came at an extremely busy time for community pharmacy and are also aware that some technical difficulties have been experienced, we hope these issues have now been resolved.
The use of secure email will be particularly important to support services from September onwards, including the new HSC commissioned flu vaccination service, it will also form a critically important means of communication within a potential COVID-19 second wave.
We would strongly encourage you to take steps to get connected by responding to the test email sent by HSCB on 19th March 2020 as soon as possible.
If you are having any difficulties please contact your local HSCB office to get these addressed.
Yours sincerely
SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive